Intratumoral Enterobacter hormaechei drives gemcitabine resistance in pancreatic cancer via cdd L ‐mediated drug inactivation
iMeta · 2026-04 · 5 (2)
DOI: 10.1002/imt2.70126 ↗Kurz gefasst
Leserbrief in der Zeitschrift iMeta, online erschienen am 29.04.2026. Verfasst von Jun-Feng Peng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Carbohydrate-Based Drug Research Center, CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materi…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Carbohydrate-Based Drug Research Center, CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai China.
- Department of Pancreatic-Biliary Surgery Second Affiliated Hospital of Naval Medical University Shanghai China.
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai China.
- School of Physical Science and Technology & State Key Laboratory of Advanced Medical Materials and Devices Shanghai Tech University Shanghai China.
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica Chinese Academy of Sciences, SSIP Healthcare and Medicine Demonstration Zone Zhongshan China.
ORCID-Profile: Meixia Li, Judong Li, Chenghao Shao, Kan Ding
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Peng, J. F., Li, M., Niu, T., Li, J., Niu, W., Zheng, M., Ji, Q., Li, C., Shao, C., & Ding, K. (2026). Intratumoral Enterobacter hormaechei drives gemcitabine resistance in pancreatic cancer via cdd L ‐mediated drug inactivation. iMeta, 5(2). https://doi.org/10.1002/imt2.70126
Vancouver
Peng JF, Li M, Niu T, Li J, Niu W, Zheng M, et al. Intratumoral Enterobacter hormaechei drives gemcitabine resistance in pancreatic cancer via cdd L ‐mediated drug inactivation. iMeta. 2026;5(2). doi:10.1002/imt2.70126
BibTeX
@article{Peng2026,
author = {Peng, Jun-Feng and Li, Meixia and Niu, Ting and Li, Judong and Niu, Wei and Zheng, Minghui and Ji, Quanjiang and Li, Chuan and Shao, Chenghao and Ding, Kan},
title = {Intratumoral Enterobacter hormaechei drives gemcitabine resistance in pancreatic cancer via cdd L ‐mediated drug inactivation},
journal = {iMeta},
year = {2026},
volume = {5},
number = {2},
doi = {10.1002/imt2.70126}
}
EUVIMED